The weekly litigation news digest is live. Subscribe now

IP Verse

Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative Disorders - EP3016654

The patent EP3016654 was granted to Bruschettini on Sep 5, 2018. The application was filed on Jul 1, 2013 under application number EP13747521A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3016654

BRUSCHETTINI
Application Number
EP13747521A
Filing Date
Jul 1, 2013
Status
Granted And Under Opposition
Aug 3, 2018
Publication Date
Sep 5, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AMMELBURGJun 4, 2019FISH & RICHARDSON PCADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2422787
INTERNATIONAL-SEARCH-REPORTWO2004096123
INTERNATIONAL-SEARCH-REPORTWO2006050165
INTERNATIONAL-SEARCH-REPORTWO2006086452
OPPOSITIONEP2422787
OPPOSITIONUS2011142799
OPPOSITIONWO2004096123
OPPOSITIONWO2006050165
OPPOSITIONWO2006086452

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents